BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18250142)

  • 1. Divide to survive: myocardial regeneration and functional recovery after cell cycle activation in injured hearts.
    Costa AD
    Cardiovasc Res; 2008 Apr; 78(1):1-2. PubMed ID: 18250142
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction.
    Hassink RJ; Pasumarthi KB; Nakajima H; Rubart M; Soonpaa MH; de la Rivière AB; Doevendans PA; Field LJ
    Cardiovasc Res; 2008 Apr; 78(1):18-25. PubMed ID: 18079102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice.
    Pasumarthi KB; Nakajima H; Nakajima HO; Soonpaa MH; Field LJ
    Circ Res; 2005 Jan; 96(1):110-8. PubMed ID: 15576649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species.
    Morimoto H; Hirose M; Takahashi M; Kawaguchi M; Ise H; Kolattukudy PE; Yamada M; Ikeda U
    Cardiovasc Res; 2008 Jun; 78(3):554-62. PubMed ID: 18267955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MRL mouse heart does not recover ventricular function after a myocardial infarction.
    Cimini M; Fazel S; Fujii H; Zhou S; Tang G; Weisel RD; Li RK
    Cardiovasc Pathol; 2008; 17(1):32-9. PubMed ID: 18160058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac progenitor cell sheet regenerates myocardium and renews hope for translation.
    Fedak PW
    Cardiovasc Res; 2010 Jul; 87(1):8-9. PubMed ID: 20430938
    [No Abstract]   [Full Text] [Related]  

  • 7. A new direction for cardiac regeneration therapy: application of synergistically acting epicardium-derived cells and cardiomyocyte progenitor cells.
    Winter EM; van Oorschot AA; Hogers B; van der Graaf LM; Doevendans PA; Poelmann RE; Atsma DE; Gittenberger-de Groot AC; Goumans MJ
    Circ Heart Fail; 2009 Nov; 2(6):643-53. PubMed ID: 19919990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ablation and mutation of nonmuscle myosin heavy chain II-B results in a defect in cardiac myocyte cytokinesis.
    Takeda K; Kishi H; Ma X; Yu ZX; Adelstein RS
    Circ Res; 2003 Aug; 93(4):330-7. PubMed ID: 12893741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-mobility group box 1 restores cardiac function after myocardial infarction in transgenic mice.
    Kitahara T; Takeishi Y; Harada M; Niizeki T; Suzuki S; Sasaki T; Ishino M; Bilim O; Nakajima O; Kubota I
    Cardiovasc Res; 2008 Oct; 80(1):40-6. PubMed ID: 18558628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiomyocyte proliferation and protection against post-myocardial infarction heart failure by cyclin D1 and Skp2 ubiquitin ligase.
    Tamamori-Adachi M; Takagi H; Hashimoto K; Goto K; Hidaka T; Koshimizu U; Yamada K; Goto I; Maejima Y; Isobe M; Nakayama KI; Inomata N; Kitajima S
    Cardiovasc Res; 2008 Nov; 80(2):181-90. PubMed ID: 18596061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium.
    Smits AM; van Laake LW; den Ouden K; Schreurs C; Szuhai K; van Echteld CJ; Mummery CL; Doevendans PA; Goumans MJ
    Cardiovasc Res; 2009 Aug; 83(3):527-35. PubMed ID: 19429921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural crest-derived stem cells migrate and differentiate into cardiomyocytes after myocardial infarction.
    Tamura Y; Matsumura K; Sano M; Tabata H; Kimura K; Ieda M; Arai T; Ohno Y; Kanazawa H; Yuasa S; Kaneda R; Makino S; Nakajima K; Okano H; Fukuda K
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):582-9. PubMed ID: 21212399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Endogenously Cycling Adult Cardiomyocytes Worsens Myocardial Function.
    Bradley LA; Young A; Li H; Billcheck HO; Wolf MJ
    Circ Res; 2021 Jan; 128(2):155-168. PubMed ID: 33146578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
    Henderson KK; Danzi S; Paul JT; Leya G; Klein I; Samarel AM
    Circ Heart Fail; 2009 May; 2(3):243-52. PubMed ID: 19808346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy.
    Busk PK; Hinrichsen R; Bartkova J; Hansen AH; Christoffersen TE; Bartek J; Haunsø S
    Exp Cell Res; 2005 Mar; 304(1):149-61. PubMed ID: 15707582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell Cycle-Mediated Cardiac Regeneration in the Mouse Heart.
    Eghbali A; Dukes A; Toischer K; Hasenfuss G; Field LJ
    Curr Cardiol Rep; 2019 Sep; 21(10):131. PubMed ID: 31529165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel beta-myosin heavy chain gene mutation, p.Met531Arg, identified in isolated left ventricular non-compaction in humans, results in left ventricular hypertrophy that progresses to dilation in a mouse model.
    Kaneda T; Naruse C; Kawashima A; Fujino N; Oshima T; Namura M; Nunoda S; Mori S; Konno T; Ino H; Yamagishi M; Asano M
    Clin Sci (Lond); 2008 Mar; 114(6):431-40. PubMed ID: 17956225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perlecan is critical for heart stability.
    Sasse P; Malan D; Fleischmann M; Roell W; Gustafsson E; Bostani T; Fan Y; Kolbe T; Breitbach M; Addicks K; Welz A; Brem G; Hescheler J; Aszodi A; Costell M; Bloch W; Fleischmann BK
    Cardiovasc Res; 2008 Dec; 80(3):435-44. PubMed ID: 18694874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro.
    Rose RA; Jiang H; Wang X; Helke S; Tsoporis JN; Gong N; Keating SC; Parker TG; Backx PH; Keating A
    Stem Cells; 2008 Nov; 26(11):2884-92. PubMed ID: 18687994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gelsolin and cardiac myocyte apoptosis: a new target in the treatment of postinfarction remodeling.
    Nishio R; Matsumori A
    Circ Res; 2009 Apr; 104(7):829-31. PubMed ID: 19359605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.